Flow Cytometry-based Detection of B-cell Lymphoproliferative Disorders in Patients with Mycosis Fungoides
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Chang T, Weaver A, Shanafelt T, Habermann T, Wriston C, Cerhan J
. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma. Int J Dermatol. 2017; 56(11):1125-1129.
PMC: 5638678.
DOI: 10.1111/ijd.13653.
View
2.
Amber K, Bloom R, Nouri K
. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Am J Clin Dermatol. 2015; 17(1):71-7.
DOI: 10.1007/s40257-015-0155-3.
View
3.
Huang K, Weinstock M, Clarke C, McMillan A, Hoppe R, Kim Y
. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Arch Dermatol. 2007; 143(1):45-50.
DOI: 10.1001/archderm.143.1.45.
View
4.
Brownell I, Etzel C, Yang D, Taylor S, Duvic M
. Increased malignancy risk in the cutaneous T-cell lymphoma patient population. Clin Lymphoma Myeloma. 2008; 8(2):100-5.
DOI: 10.3816/CLM.2008.n.011.
View
5.
Barzilai A, Trau H, David M, Feinmesser M, Bergman R, Shpiro D
. Mycosis fungoides associated with B-cell malignancies. Br J Dermatol. 2006; 155(2):379-86.
DOI: 10.1111/j.1365-2133.2006.07346.x.
View